Patent · US Active

Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof

US8394810B2 · kind B2 · utility

30Cited by
4References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 21, 2011
Grant dateMar 12, 2013
Priority date
Expiry dateFeb 19, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to novel “reverse amide” compounds comprising a zinc chelator group, and the use of such compounds in the inhibition of HDAC6 and in the treatment of various diseases, disorders or conditions related to HDAC6.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.